Opinion
Video
Focusing on elacestrant, Dr Graff discusses the role of oral SERDs (selective estrogen receptor degraders) in the treatment of patients with ER+/HER2- metastatic breast cancer.
Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Reviving the Classics: The Role of Older Medications in Modern Dermatology
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
Improving Social Determinants of Health Essential for Better AD Outcomes in Pediatric Patients of Color